Alergologia Polska - Polish Journal of Allergology
eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Publication charge Supplements Special issues Instructions for authors Publication charge
Editorial System
Submit your Manuscript
Share:
Share:
Review paper

Co-occurrence of atopic dermatitis with obesity, diabetes, and autoimmune thyroid diseases

Monika Kamińska
1
,
Katarzyna Moczyróg
2

  1. Non-public Health Care Facility “PROMED”, Kielce, Poland
  2. The Sergeant Grzegorz Załoga Hospital of the Ministry of the Interior and Administration, Katowice, Poland
Alergologia Polska – Polish Journal of Allergology
Online publish date: 2026/05/06
Article file
- Co-occurrence.pdf  [0.24 MB]
Get citation
 
PlumX metrics:
 
1. Shang D, Zhao S. Molecular mechanisms of obesity predisposes to atopic dermatitis. Front Immunol 2024; 15: 1473105.
2. McAleer JP. Obesity and the microbiome in atopic dermatitis: therapeutic implications for PPAR-γ agonists. Front Allergy 2023; 4: 1167800.
3. Sendrea AM, Salavastru CM. Atopische Dermatitis und Diabetes mellitus – Gibt es Zusammenhänge? [Atopic dermatitis and diabetes mellitus-is there a link?]. Dermatologie (Heidelb) 2025; 76: 21-6.
4. Zhou W, Cai J, Li Z, et al. Association of atopic dermatitis with autoimmune diseases: a bidirectional and multivariable two-sample mendelian randomization study. Front Immunol 2023; 14: 1132719.
5. Mendiratta V, Himadri H, Verma D, et al. Is atopic dermatitis a risk factor for thyroid autoimmunity? A cross-sectional study from a Tertiary Care Center in India. Indian Dermatol Online J 2023; 15: 45-8.
6. Carlucci P, Spataro F, Cristallo M, et al. Immune-molecular link between thyroid and skin autoimmune diseases: a narrative review. J Clin Med 2024; 13: 5594.
7. Guo Z, Yang Y, Liao Y, et al. Emerging roles of adipose tissue in the pathogenesis of psoriasis and atopic dermatitis in obesity. JID Innov 2021; 2: 100064.
8. Zhang Y, Wei Q, Chen Q. Potential shared mechanisms in atopic dermatitis and type 2 diabetes identified via transcriptomic and machine learning approaches. Sci Rep 2024; 14: 30467. Erratum in: Sci Rep 2025; 15: 6248.
9. Daramjav N, Takagi J, Iwayama H, et al. Autoimmune thyroiditis shifting from hashimoto’s thyroiditis to Graves’ disease. Medicina (Kaunas) 2023; 59: 757.
10. Zhang C, Hong C, Lian X, et al. Correlations of thyroid autoantibodies with allergic diseases: a case-control study of 434 Chinese patients. Medicine (Baltimore) 2022; 101: e29871.
11. Moczyróg K, Mól P, Kamińska M, et al. Farmakologiczne leczenie otyłości w praktyce lekarza rodzinnego. FMR 2025; 19: 62-73.
12. Schleh MW, Caslin HL, Garcia JN, et al. Metaflammation in obesity and its therapeutic targeting. Sci Transl Med 2023; 15: eadf9382.
13. Rohm TV, Meier DT, Olefsky JM, et al. Inflammation in obesity, diabetes, and related disorders. Immunity 2022; 55: 31-55.
14. Russo S, Kwiatkowski M, Govorukhina N, et al. Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites. Front Immunol 2021; 12: 746151.
15. Abi Saleh R, Lirette ST, Benjamin EJ, et al. Mediation effects of diabetes and inflammation on the relationship of obesity to cognitive impairment in African Americans. J Am Geriatr Soc 2022; 70: 3021-9.
16. Kamińska M, Miernik-Skrzypczak M, Spyra A, et al. The effect of incretin antidiabetic drugs on obesity, cardiovascular system, and kidneys. FMR 2025; 19: 62-73.
17. Kamińska M, Jasiewicz M, Miernik-Skrzypczak M, et al. The importance of stem cells in the treatment of type 1 diabetes, type 2 diabetes and diabetes complications: the importance of stem cells in diabetology. Qual Sport 2025; 37: 57420.
18. Kamińska M, Kozioł A, Miernik-Skrzypczak M, et al. Vitamin D supplementation in selected autoimmune diseases. Qual Sport 2024; 27: 55650.
19. Antar SA, Ashour NA, Sharaky M, et al. Diabetes mellitus: classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother 2023; 168: 115734.
20. Vargas-Uricoechea H. Molecular mechanisms in autoimmune thyroid disease. Cells 2023; 12: 918.
21. Martinez Quintero B, Yazbeck C, Sweeney LB. Thyroiditis: evaluation and treatment. Am Fam Physician 2021; 104: 609-17.
22. Zheng H, Xu J, Chu Y, et al. A Global Regulatory Network for dysregulated gene expression and abnormal metabolic signaling in immune cells in the microenvironment of Graves’ disease and Hashimoto’s thyroiditis. Front Immunol 2022; 13: 879824.
23. Knezevic J, Starchl C, Tmava Berisha A, et al. Thyroid-gut-axis: how does the microbiota influence thyroid function? Nutrients 2020; 12: 1769.
24. Oueslati I, Salhi S, Yazidi M, et al. A case of Hashimoto’s thyroiditis following Graves’ disease. Clin Case Rep 2022; 10: e6466.
25. Legakis I, Chrousos GP, Chatzipanagiotou S. Thyroid diseases and intestinal microbiome. Horm Metab Res 2023; 55: 813-8.
26. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 2014; 71: 116-32.
27. AAAAI/ACAAI JTF Atopic Dermatitis Guideline Panel; Chu DK, Schneider L, Asiniwasis RN, et al. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations. Ann Allergy Asthma Immunol 2024; 132: 274-312.
28. Wollenberg A, Kinberger M, Arents B, et al. EuroGuiDerm guideline on atopic eczema. Version 3.0. European Dermatology Forum; 2025 Mar. Available from: https://www.guidelines.edf.one/guidelines/atopic-ezcema [cited 2025 Jul 23].
29. Akan A, Dibek-Mısırlıoğlu E, Civelek E, et al. Diagnosis of atopic dermatitis in children: comparison of the Hanifin-Rajka and the United Kingdom Working Party criteria. Allergol Immunopathol (Madr) 2020; 48: 175-81.
30. Saeki H, Ohya Y, Arakawa H, et al.; Committee for Clinical Practice Guidelines for the Management of Atopic Dermatitis 2024; Japanese Society of Allergology; Japanese Dermatology Association. Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2024. Allergol Int 2025; 74: 210-21.
31. Atopowe zapalenie skóry. Interdyscyplinarne rekomendacje dia­gnostyczno-terapeutyczne Polskiego Towarzystwa Dermatolo­gicznego, Polskiego Towarzystwa Alergologicznego, Polskiego Towarzystwa Pediatrycznego oraz Polskiego Towarzystwa Medycyny Rodzinnej. Część II. Leczenie ogólne oraz nowe metody terapeutyczne. Polskie Towarzystwo Dermatologiczne; 2020 Jan. https://www.ptderm.com.pl/dokumenty-do-pobrania/atopowe-zapalenie-skory [cited 2025 Jul 31].
32. Atopowe zapalenie skóry. Interdyscyplinarne rekomendacje diagnostyczno-terapeutyczne Polskiego Towarzystwa Dermatologicznego, Polskiego Towarzystwa Alergologicznego, Polskiego Towarzystwa Pediatrycznego oraz Polskiego Towarzystwa Medycyny Rodzinnej. Część I. Profilaktyka, leczenie miejscowe i fototerapia. Polskie Towarzystwo Dermatologiczne; 2020 Jan. https://www.ptderm.com.pl/dokumenty-do-pobrania/atopowe-zapalenie-skory [cited 2025 Jul 31].
Copyright: © Polish Society of Allergology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.



Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.